- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Lawmakers Nearing SGR Deal
Although a deal is not yet final, aides say the general framework is likely to include a 10-month straight extension of the current Medicare payment rate to physicians. The agreement is also likely to extend certain Medicare programs, but on the condition that there be greater reporting and accountability of those programs from the CMS, the Medicare Payment Advisory Commission and the Government Accountability Office.
Source: Modern Healthcare
Federal lawmakers on Tuesday evening inched closer to an agreement on a short-term solution to Medicare's sustainable growth-rate formula for physicians. If Congress does not act by Feb. 29, doctors who participate in the federal healthcare program will face a 27.4% cut in their Medicare reimbursement.
Trump Administration’s Message to Supreme Court Puts New Wrinkle in Braidwood Case
February 21st 2025The Trump administration argues that HHS Secretary Robert F. Kennedy Jr can overrule the US Preventive Services Task Force to determine the preventive services covered under the Affordable Care Act.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Same-Day Breast Imaging Gaps Reveal Health Care Disparities
February 18th 2025For this retrospective study, the authors examined data on more than 3 million screening mammographies for more than 1 million female patients; of the screenings, 23.6% had abnormal results and only 6.7% were recommended for biopsy.
Read More
